Liver Transplant and Chronic Hepatitis B Virus Infection
| dc.contributor.author | Selcuk, Haldun | |
| dc.contributor.author | Haberal, Mehmet | |
| dc.contributor.author | Karakayali, Hamdi | |
| dc.date.accessioned | 2026-04-01T09:22:18Z | |
| dc.date.issued | 2011-04 | |
| dc.description.abstract | Hepatitis B immune globulin use for preventing hepatitis B virus recurrence after liver transplant has changed our behavior radically, and it now seems that hepatitis B immune globulin has a vital role in preventing recurrence. New nucleotide or nucleoside analogues have promising results in treating chronic hepatitis and in posttransplant hepatitis B virus-infected patients. Hepatitis B immune globulin and other antivirals act on different pathways, so it is logical to combine these drugs to achieve maximum response in suppressing hepatitis B virus (HBV)-replication. | |
| dc.identifier.citation | Experimental and Clinical Transplantation, Cilt, 9, Sayı, 2, 2011 ss. 94-97 | en |
| dc.identifier.eissn | 2146-8427 | en |
| dc.identifier.issn | 1304-0855 | |
| dc.identifier.issue | 2 | en |
| dc.identifier.uri | https://hdl.handle.net/11727/14709 | |
| dc.identifier.volume | 9 | en |
| dc.language.iso | en | |
| dc.publisher | Başkent Üniversitesi | |
| dc.source | Experimental and Clinical Transplantation | en |
| dc.subject | Chronic Hepatitis B | |
| dc.subject | Virus Infection | |
| dc.title | Liver Transplant and Chronic Hepatitis B Virus Infection | |
| dc.type | Review |